"Despite the well-established safety and effectiveness of non-live vaccination in individuals with IBD, including those on immunomodulators and biologic therapy, vaccine uptake in pregnant women ...

Before and During the Induction Phase of Treatment The single most important factor for optimization of therapy for IBD at the initiation of treatment is ascertainment of active IBD inflammation.

Greater access to innovative treatments could be linked to a drop in patients requiring surgery for a type of inflammatory bowel disease, a 20-year study suggests.